The Jewish people: their ethnic history, genetic disorders and specific cancer susceptibility (Q35934025)

11 August 2017

1 reference

title

The Jewish people: their ethnic history, genetic disorders and specific cancer susceptibility (English)

1 reference

11 August 2017

Inbal Kedar-Barnes

1

1 reference

11 August 2017

Paul Rozen

series ordinal

2

1 reference

11 August 2017

publication date

1 January 2004

1 reference

11 August 2017

1 reference

11 August 2017

volume

3

1 reference

11 August 2017

issue

3-4

1 reference

11 August 2017

page(s)

193-199

1 reference

Shared genetic susceptibility to breast cancer, brain tumors, and Fanconi anemia

11 August 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007/S10689-004-9544-0

The possibility of a selection process in the Ashkenazi Jewish population

21 January 2018

1 reference

12 December 2020

Fanconi anemia and leukemia: tracking the genes

1 reference

12 December 2020

A636P is associated with early-onset colon cancer in Ashkenazi Jews.

1 reference

12 December 2020

A prospective study of the clinical, genetic, screening, and pathologic features of a family with hereditary mixed polyposis syndrome.

1 reference

12 December 2020

Jewish and Middle Eastern non-Jewish populations share a common pool of Y-chromosome biallelic haplotypes

1 reference

12 December 2020

Familial colorectal cancer in Ashkenazim due to a hypermutable tract in APC

1 reference

12 December 2020

Geographic distribution of disease mutations in the Ashkenazi Jewish population supports genetic drift over selection

1 reference

12 December 2020

An ancestral Ashkenazi haplotype at the HMPS/CRAC1 locus on 15q13-q14 is associated with hereditary mixed polyposis syndrome

1 reference

12 December 2020

The Y chromosome pool of Jews as part of the genetic landscape of the Middle East

1 reference

12 December 2020

Recurrent BRCA2 6174delT mutations in Ashkenazi Jewish women affected by breast cancer

1 reference

12 December 2020

Founder BRCA1 and BRCA2 mutations in Ashkenazi Jews in Israel: frequency and differential penetrance in ovarian cancer and in breast-ovarian cancer families

1 reference

12 December 2020

The founder mutation MSH2*1906G-->C is an important cause of hereditary nonpolyposis colorectal cancer in the Ashkenazi Jewish population

1 reference

12 December 2020

Germ-line BRCA1 mutations in Jewish and non-Jewish women with early-onset breast cancer

1 reference

12 December 2020

The Tyr978X BRCA1 Mutation in Non-Ashkenazi Jews: Occurrence in High-Risk Families, General Population and Unselected Ovarian Cancer Patients

1 reference

12 December 2020

Bloom syndrome and Fanconi's anemia: rate and ethnic origin of mutation carriers in Israel

1 reference

12 December 2020

Biallelic inactivation of BRCA2 in Fanconi anemia

1 reference

12 December 2020

Numerous colonic adenomas in an individual with Bloom's syndrome

1 reference

12 December 2020

The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1%

1 reference

12 December 2020

The 185delAG BRCA1 mutation originated before the dispersion of Jews in the diaspora and is not limited to Ashkenazim

1 reference

12 December 2020

Could the 185delAG BRCA1 mutation be an ancient Jewish mutation?

1 reference

12 December 2020

The Tay-Sachs disease gene in North American Jewish populations: geographic variations and origin

1 reference

12 December 2020

Fanconi anaemia group A (FANCA) mutations in Israeli non-Ashkenazi Jewish patients.

1 reference

12 December 2020

The 8765delAG Mutation in BRCA2 Is Common among Jews of Yemenite Extraction

1 reference

12 December 2020

Founding mothers of Jewish communities: geographically separated Jewish groups were independently founded by very few female ancestors

1 reference

12 December 2020

The differences among Jewish communities--maternal and paternal contributions

1 reference

12 December 2020

Genetic analysis of familial colorectal cancer in Israeli Arabs

1 reference

12 December 2020

The founder mutations 185delAG and 5382insC in BRCA1 and 6174delT in BRCA2 appear in 60% of ovarian cancer and 30% of early-onset breast cancer patients among Ashkenazi women

1 reference

12 December 2020

Clinical and screening implications of the I1307K adenomatous polyposis coli gene variant in Israeli Ashkenazi Jews with familial colorectal neoplasia. Evidence for a founder effect

1 reference

12 December 2020

Cancer incidence in persons with Fanconi anemia.

1 reference

12 December 2020

10.1007/S10689-004-9544-0

Identifiers

DOI

1 reference

11 August 2017

1 reference